Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oxford BioMedica PLC
OXBCurrent price
417 GBX
-18.41 GBX (-4.25%)
Last closed
415.5 GBX
Company
www.oxb.com
ISIN
GB00BDFBVT43
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
432 533 472 GBX
Yield for 12 month
+95.77 %
1Y
3Y
5Y
10Y
15Y
OXB
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom. Address: Windrush Court, Oxford, United Kingdom, OX4 6LT
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
34 679.39 GBXP/E ratio
–Dividend Yield
–Current Year
+8 961 602 159 GBX
Last Year
+14 010 941 879 GBX
Current Quarter
+5 084 970 306 GBX
Last Quarter
+4 651 798 068 GBX
Current Year
+3 923 271 880 GBX
Last Year
+6 924 050 932 GBX
Current Quarter
+1 797 044 456 GBX
Last Quarter
+1 780 330 160 GBX
Key Figures OXB
1 year
3 years
5 years
10 years
EBITDA
-55 990 128 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-12.67 %
PEG Ratio
–
Return On Equity TTM
-124.66 %
Wall Street Target Price
34 679.39 GBX
Revenue TTM
97 367 684 GBX
Book Value
0.63 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
18 %
Dividend Yield
–
Gross Profit TTM
82 711 087 GBX
Earnings per share
-1.44 GBX
Diluted Eps TTM
-1.44 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
106.9 %
Profit Margin
-145.98 %
Dividend Analytics OXB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OXB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
30.05.2018
Dividend Date
–
Stock Valuation OXB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
250
Enterprise Value Revenue
4.7066
Price Sales TTM
4.4423
Enterprise Value EBITDA
-819.7258
Price Book MRQ
6.4742
Financials OXB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OXB
For 52 weeks
164.43 GBX
450.39 GBX
50 Day MA
371.41 GBX
Shares Short Prior Month
–
200 Day MA
294.67 GBX
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart